Published in Crit Care Med on April 01, 2010
Early Postoperative Blood Glucose Variability and Outcome After TAVI (GLYTAVI) | NCT02726958
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66
Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med (2011) 1.42
Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care (2011) 1.30
The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care (2013) 1.28
Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care (2010) 1.17
Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data. Crit Care (2012) 1.13
LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care (2012) 1.05
Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care (2015) 1.04
The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev (2011) 1.04
Population physiology: leveraging electronic health record data to understand human endocrine dynamics. PLoS One (2012) 1.03
Glycemic variability in critical illness and the end of Chapter 1. Crit Care Med (2010) 1.00
Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Ann Intensive Care (2011) 0.98
The role of pre-operative and post-operative glucose control in surgical-site infections and mortality. PLoS One (2012) 0.93
Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol (2011) 0.92
Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin. Crit Care (2014) 0.90
Increasing blood glucose variability is a precursor of sepsis and mortality in burned patients. PLoS One (2012) 0.88
Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all! Crit Care (2013) 0.88
Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes. Chest (2013) 0.87
Clinical impact of sample interference on intensive insulin therapy in severely burned patients: a pilot study. J Burn Care Res (2014) 0.86
The impact of measurement frequency on the domains of glycemic control in the critically ill--a Monte Carlo simulation. J Diabetes Sci Technol (2015) 0.85
Infectious complications of cardiac surgery: a clinical review. J Cardiothorac Vasc Anesth (2012) 0.83
Critical illness-induced dysglycaemia: diabetes and beyond. Crit Care (2010) 0.83
Average daily risk range as a measure of glycemic risk is associated with mortality in the intensive care unit: a retrospective study in a burn intensive care unit. J Diabetes Sci Technol (2011) 0.81
Glycemic variability and outcome in critically ill. Indian J Crit Care Med (2014) 0.80
Assessment of blood glucose control in the pediatric intensive care unit: extension of the glycemic penalty index toward children and infants. J Diabetes Sci Technol (2011) 0.79
Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care (2010) 0.79
[Assessment and treatment of hyperglycemia in critically ill patients]. Rev Bras Ter Intensiva (2014) 0.79
Endocrine and metabolic emergencies: hypoglycaemia. Ther Adv Endocrinol Metab (2011) 0.79
The benefits of tight glycemic control in critical illness: Sweeter than assumed? Indian J Crit Care Med (2014) 0.78
Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care (2015) 0.78
Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm! Intensive Care Med (2016) 0.78
Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions. Diabetol Metab Syndr (2014) 0.77
Full neurological recovery after extreme hypoglycemia during intensive insulin therapy: a case report. J Diabetes Sci Technol (2012) 0.76
Management of critically ill patients with type 2 diabetes: The need for personalised therapy. World J Diabetes (2015) 0.76
Perioperative glucose control in neurosurgical patients. Anesthesiol Res Pract (2012) 0.76
Glycemic variability is complex--is glucose complexity variable? Crit Care (2012) 0.75
Familial Longevity Is Not Associated with Major Differences in the Hypothalamic-Pituitary-Gonadal Axis in Healthy Middle-Aged Men. Front Endocrinol (Lausanne) (2016) 0.75
Parenteral feeding and intensive insulin therapy. Crit Care Med (2010) 0.75
Glycemic control in critically ill: A moving target. Indian J Crit Care Med (2014) 0.75
Evaluation of a Nurse-Managed Insulin Infusion Protocol. Diabetes Technol Ther (2015) 0.75
Multiplicative surrogate standard deviation: a group metric for the glycemic variability of individual hospitalized patients. J Diabetes Sci Technol (2013) 0.75
Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients. PLoS One (2016) 0.75
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Early versus late parenteral nutrition in critically ill adults. N Engl J Med (2011) 12.10
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet (2009) 6.44
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 6.01
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med (2003) 5.92
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med (2013) 4.22
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr (2009) 4.11
Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09
Nutrition in the acute phase of critical illness. N Engl J Med (2014) 4.02
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 3.90
Tight blood glucose control with insulin in the ICU: facts and controversies. Chest (2007) 3.79
Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J Clin Oncol (2009) 3.58
Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes (2006) 3.56
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology (2013) 3.55
Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res (2008) 3.33
A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol Cell (2007) 3.23
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev (2008) 3.16
Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA (2012) 3.16
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09
Quantum-sized carbon dots for bright and colorful photoluminescence. J Am Chem Soc (2006) 3.08
Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy. Clin Cancer Res (2013) 3.01
Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet (2006) 2.99
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron (2006) 2.88
Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med (2013) 2.81
Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell (2005) 2.75
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica (2006) 2.75
Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med (2014) 2.68
Amino acid concentrations in critically ill children following cardiac surgery*. Pediatr Crit Care Med (2014) 2.65
A novel sRNA component of the carbon storage regulatory system of Escherichia coli. Mol Microbiol (2003) 2.63
Ancient pinnate leaf mimesis among lacewings. Proc Natl Acad Sci U S A (2010) 2.56
Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care (2006) 2.46
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest (2003) 2.42
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury. J Cell Biol (2010) 2.40
Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Opt Lett (2007) 2.34
Activator control of nucleosome occupancy in activation and repression of transcription. PLoS Biol (2008) 2.29
The plasticity of human maternal brain: longitudinal changes in brain anatomy during the early postpartum period. Behav Neurosci (2010) 2.23
Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med (2006) 2.22
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med (2006) 2.21
Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol (2005) 2.16
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med (2012) 2.14
Acute phase homocysteine related to severity and outcome of atherothrombotic stroke. Eur J Intern Med (2013) 2.13
c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res (2002) 2.11
Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest (2005) 2.11
Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci (2011) 2.11
Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli. J Bacteriol (2002) 2.10
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med (2009) 2.10
Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns. Am J Hypertens (2013) 2.08
Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis (2006) 2.07
Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis. Chin Med J (Engl) (2015) 2.04
Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg (2014) 2.04
Motivations and methods for analyzing pulsatile hormone secretion. Endocr Rev (2008) 2.01
A RSC/nucleosome complex determines chromatin architecture and facilitates activator binding. Cell (2010) 2.00
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab (2003) 1.93
Functional TRPV4 channels are expressed in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.92
Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab (2003) 1.92
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis (2009) 1.92
Carbon dots for multiphoton bioimaging. J Am Chem Soc (2007) 1.89
Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol (2011) 1.85
MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun (2010) 1.80
Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med (2013) 1.78
Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet (2005) 1.78
Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology (2012) 1.76
Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol (2003) 1.76
Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens (2004) 1.75
Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun (2003) 1.74
Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes (2005) 1.73
Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care (2013) 1.72
Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci (2013) 1.72
Disruption of Gja8 (alpha8 connexin) in mice leads to microphthalmia associated with retardation of lens growth and lens fiber maturation. Development (2002) 1.72
Clinical review: Critical illness polyneuropathy and myopathy. Crit Care (2008) 1.69
Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue. J Biomed Opt (2007) 1.68
CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther (2010) 1.68
Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes (2002) 1.68
Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol (2008) 1.67
Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res (2010) 1.67
Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun (2013) 1.65
catena-Poly[[aqua-(dipyrido[3,2-a:2',3'-c]phenazine-κN,N)zinc(II)]-μ-pyrazine-2,3-dicarboxyl-ato-κN,O:O]. Acta Crystallogr Sect E Struct Rep Online (2008) 1.65